Real Relief Tablet
NDC Package 65808-324-01
Package Information
Real Relief (apis mellifica, arnica montana, benzoicum acidum, causticum, colchicum autumnale, natrum carbonicum) tablets is usesThis homeopathic medicine is made from a combination of ingredients traditionally used to help relieve symptoms associatedwith arthritisjoint painstiffnessinflammationsoreness. This formulation utilizes a tablet delivery system. Marketed by Gmp Laboratories Of America, Inc., this product is identified by NDC 65808-324.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Ammonium Ion Binding Activity - [MoA] (Mechanism of Action)
- Bee Venoms - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Nitrogen Binding Agent - [EPC] (Established Pharmacologic Class)
- Standardized Insect Venom Allergenic Extract - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 65808 - Gmp Laboratories Of America, Inc.
- 65808-324 - Real Relief
- 65808-324-01 - 1 BOTTLE in 1 CARTON / 90 TABLET in 1 BOTTLE
- 65808-324 - Real Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65808-324-01 identifies a specific commercial package of 1 bottle in 1 carton / 90 tablet in 1 bottle of Real Relief, a human over the counter drug labeled by Gmp Laboratories Of America, Inc.. This tablet is formulated for oral use and contains apis mellifera; arnica montana; benzoic acid; causticum; colchicum autumnale bulb; sodium carbonate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Gmp Laboratories Of America, Inc. on January 01, 2020. The current certification is valid through December 31, 2026.
How is this Gmp Laboratories Of America, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65808032401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.